跳至主要内容
临床试验/NCT01068002
NCT01068002已完成不适用

Hypertension During Pregnancy: Cardiovascular & Echocardiographic Assessment: CREATION - P (01)

HaEmek Medical Center, Israel1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2009年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
1
主要终点
Hypertension impact on cardiovascular echocardiographic parameters and obstetric parameters in pregnant women with or without treatment

研究概览

简要总结

Cardiovascular & echocardiographic assessment in pregnant women with hypertension during their pregnancy in comparison to Pregnant normotensive women.

详细描述

Cardiovascular & echocardiographic assessment in pregnant women with hypertension during their pregnancy in comparison to Pregnant normotensive women. Also,comparing echocardiographic parameters in hypertensive pregnant women being treated with either alfa methyl dopa or labetolol.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • hypertension during pregnancy: Chronic or pregnancy induced

排除标准

  • Inability to sign informed consent

结局指标

主要结局

Hypertension impact on cardiovascular echocardiographic parameters and obstetric parameters in pregnant women with or without treatment

时间窗: 1 year

次要结局

  • Primary outcome, Impact of alfa methyl dopa and labetolol on cardiovascular parameters in pregnant women(1 Year)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验